AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...

Humble brag: I reckon I could spot a fitness gimmick a mile off. As WH’s Fitness Editor, I spend pretty much all day everyday reading/writing about the latest workout trends. I’m also kind of addicted ...